Navigation Links
Patient Safety Technologies Reports Second Quarter 2010 Results
Date:8/17/2010

ed to expand adoption of our Safety-Sponge® System; any failure of our new management team and Board of Directors to operate effectively; our reliance on third-party manufacturers, some of whom are sole-source suppliers, and on our exclusive distributor; and any inability to successfully protect our intellectual property portfolio.  In light of the risks and uncertainties, there can be no assurance that any forward-looking statement will in fact prove to be correct.

Forward-looking statements can be affected by many other factors, including, those described in the "Business" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of our Annual Report on Form 10-K for 2009 and in our other public filings. These documents are available online through the SEC's website, www.sec.gov. Forward-looking statements are based on information presently available to senior management, and we have not assumed any duty to update any forward-looking statements


'/>"/>
SOURCE Patient Safety Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. Many Heart Attack Patients Dont Get Best Emergency Treatment
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... July 30, 2015 Edwards Lifesciences Corporation (NYSE: ... valves and hemodynamic monitoring, today announced that Robert A. ... "Bob is an ardent champion for innovation in ... to have him on Edwards, board as we pursue our ... chairman and CEO.  "Bob has provided a valuable perspective to ...
(Date:7/30/2015)... 2015  ResMed Inc. (NYSE: RMD ) today ...  Revenue for the quarter was $453.1 million, a 9 ... 2014 (a 17 percent increase on a constant currency ... quarter ended June 30, 2014.  Diluted earnings per share ... ended June 30, 2014.  The results ...
(Date:7/30/2015)... ROCHELLE PARK, N.J. , July 30, 2015 /PRNewswire/ ... is voluntarily recalling one lot of Hydrochlorothiazide tablets 25 ... has been initiated as a precautionary measure due to ... bottle of the product. The risk ... a Hydrochlorothiazide tablet is the increased probability of experiencing ...
Breaking Medicine Technology:ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 3ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 4ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 5ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 7ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 8ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 9ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 10ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 11ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 12ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 13ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 14ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 15ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 16Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2
... Sept. 7 Sun Pharmaceutical Industries Ltd. (Sun) (Reuters: ... announced that the Supreme Court of Israel has unanimously ... (Pink Sheets: TAROF ) of the previous ... Israeli special tender offer (STO) rules do not apply ...
... Cincinnati-based market leader in echogenic needles, has announced ... which could help reduce radiation exposure.  Last month, ... their new, innovative Micro Laser Etching (MLE™) technology, ... waves back to the transducer even at steep ...
Cached Medicine Technology:Supreme Court of Israel Rules in Favor of Sun Pharma 2Supreme Court of Israel Rules in Favor of Sun Pharma 3Havel's Incorporated Helping to Reduce Radiation Exposure with New EchoTuohy™ Ultrasound Needle 2
(Date:8/1/2015)... ... ... “ reTXT ” was featured on NewsWatch as part of its monthly AppWatch, which ... Android, and Windows. Joe Toohey, the host of AppWatch and technology expert, conducted the ... message including ones already sent. , While text messaging has more features than it ...
(Date:7/31/2015)... ... July 31, 2015 , ... That’s right, the ... the STASH awards? The Significant Technological Achievements in Secretive Horticulture (or STASH) Awards, ... as tried-and-true products that have stood the test of time. These include lighting ...
(Date:7/31/2015)... New York, New York (PRWEB) , ... July 31, 2015 , ... ... started to strut their stuff, Super-Sod debuted their new type of sod called ... with registered trademark application in process. , To commemorate introduction of this new type ...
(Date:7/31/2015)... ... ... Super Bowl 50 will emanate from Levi’s Stadium in Santa Clara, CA on Sunday, ... Bowl. In the two weeks that separate the conference championships and the Super Bowl, there ... game will mark the 50th time it has been held and the festivities will take ...
(Date:7/31/2015)... ... 31, 2015 , ... Precision Aesthetics is New York’s only Thermage skin tightening ... first provider of Exilis non-surgical fat reduction in New York. Due to its ... large International clientele. Many patients travel to New York to get their non-surgical ...
Breaking Medicine News(10 mins):Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2
... today,announced that the technology they have developed shows promising ... researchers as an early,warning system for heat injury. ... research from a university as respected as, Kennesaw State ... we anticipated, in,the preliminary stages of research that the ...
... LONDON, Feb. 17 Cancer may well surpass cardiovascular,diseases ... 2012. To prevent this from,happening, cancer therapeutics have ... offering a total cure, despite the complex, multifactorial nature,of ... http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) , "As cancer ...
... BUDS ... FRESH LEMONS CAN ADD PIZAZZ TO OTHERWISE PLAIN ... Creative cooking is at its finest during the forty days ... up their favorite foods in preparation for Easter. Supplies of ... and favor for traditional meatless meals as well as helping ...
... HUNTINGTON BEACH, Calif., Feb. 17 Forterus Healthcare, a ... announced the completion of its acquisition of Solutions 4 ... treatment center, effective Feb. 2nd. Forterus Healthcare is now ... new company, Dana Point Recovery Inc., which will serve ...
... Pharmaceuticals Inc. (BMR.TSX), provided an update today on ... in the most advanced form of brain cancer ... Directors has recommended a review of strategic options ... projections of site initiation and patient enrollment from ...
... Focus on Skilled Geriatric Home Health CareMELVILLE, N.Y., Feb. ... GTIV ), a leading provider of comprehensive home health ... Asset Purchase Agreement with Andventure Inc., doing business as ... six Gentiva branch offices in four cities that specialize ...
Cached Medicine News:Health News:HotHead Technologies' Heat Sensor Shows Exciting Potential by Kennesaw State University Researchers 2Health News:Frost & Sullivan Says, Innovative Therapies Needed to Deal With the Rapid Spread of Cancer in Europe 2Health News:Frost & Sullivan Says, Innovative Therapies Needed to Deal With the Rapid Spread of Cancer in Europe 3Health News:Frost & Sullivan Says, Innovative Therapies Needed to Deal With the Rapid Spread of Cancer in Europe 4Health News:Sunkist(R) Lemons Freshen Up Lenten Foods 2Health News:Sunkist(R) Lemons Freshen Up Lenten Foods 3Health News:Forterus Healthcare Continues Its Southern California Expansion, Completing Its Second Acquisition in Six Months 2Health News:Bradmer provides clinical trial update and announces evaluation of strategic alternatives 2Health News:Bradmer provides clinical trial update and announces evaluation of strategic alternatives 3Health News:Bradmer provides clinical trial update and announces evaluation of strategic alternatives 4Health News:Gentiva(R) Health Services Sells Selected Pediatric Home Health Care Branches 2Health News:Gentiva(R) Health Services Sells Selected Pediatric Home Health Care Branches 3Health News:Gentiva(R) Health Services Sells Selected Pediatric Home Health Care Branches 4
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
Medicine Products: